Product Recalls in North Carolina

Product recalls affecting North Carolina — including food, drugs, consumer products, medical devices, and vehicles distributed to North Carolina. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,779 recalls have been distributed to North Carolina in the last 12 months.

54,363 total recalls
2,779 in last 12 months

Showing 1134111360 of 13,606 recalls

DrugOctober 1, 2014· Hospira Inc.

Recalled Item: Hydromorphone Hydrochloride Injection Recalled by Hospira Inc. Due to Lack...

The Issue: Lack Of Assurance Of Sterility: Confirmed customer complaints of glass...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 1, 2014· Avella of Deer Valley, Inc.

Recalled Item: HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL) Recalled by Avella of...

The Issue: Crystallization: Formation of crystals observed in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 30, 2014· Gilead Sciences, Inc.

Recalled Item: Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate)...

The Issue: Presence of Foreign Substance: Truvada was found to contain small red...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 29, 2014· Baxter Healthcare Corp.

Recalled Item: DOPamine Hydrochloride and 5% Dextrose INJ Recalled by Baxter Healthcare...

The Issue: Lack of Assurance of Sterility: A small cut in the solution bag may have...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 26, 2014· Forest Pharmaceuticals Inc

Recalled Item: Bystolic (nebivolol) tablets Recalled by Forest Pharmaceuticals Inc Due to...

The Issue: Failed Dissolution Specification; at the 6-month stability time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 26, 2014· Actavis Laboratories, FL, Inc.

Recalled Item: Diclofenac Sodium and Misoprostol Delayed-Release Tablets Recalled by...

The Issue: Failed Tablet/Capsule Specifications: Presence of split or broken tablets.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 26, 2014· Sun Pharma Global Inc.

Recalled Item: Venlafaxine Hydrochloride Extended-Release Tablets Recalled by Sun Pharma...

The Issue: Failed Dissolution Specifications; 12 month stability time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 24, 2014· Zydus Pharmaceuticals USA Inc

Recalled Item: BENZONATATE Capsules Recalled by Zydus Pharmaceuticals USA Inc Due to...

The Issue: Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 18, 2014· Bracco Diagnostic Inc

Recalled Item: E-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent Recalled by Bracco...

The Issue: Subpotent Drug: Out of Specification (OOS) result during routine stability...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 17, 2014· Janssen Ortho L.L.C.

Recalled Item: Xarelto (rivaroxaban) Tablets 15 mg per tablet Recalled by Janssen Ortho...

The Issue: Microbial Contamination of Non-Sterile Products: Consumer complaint...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 15, 2014· Zydus Pharmaceuticals USA Inc

Recalled Item: TOPIRAMATE Tablets 200 mg Recalled by Zydus Pharmaceuticals USA Inc Due to...

The Issue: Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 15, 2014· Astellas Pharma US Inc

Recalled Item: Tarceva (erlotinib) Tablets Recalled by Astellas Pharma US Inc Due to Failed...

The Issue: Failed Dissolution Specifications: The product did not meet the acceptance...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 15, 2014· AbbVie Inc

Recalled Item: CREON (pancrelipase) Delayed-Release Capsules Recalled by AbbVie Inc Due to...

The Issue: Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 11, 2014· Hospira Inc.

Recalled Item: HEPARIN SODIUM Recalled by Hospira Inc. Due to Presence of Particulate...

The Issue: Presence of Particulate Matter: A particulate, confirmed as human hair, was...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugSeptember 11, 2014· Qualitest Pharmaceuticals

Recalled Item: MethylPREDNISolone TABLETS Recalled by Qualitest Pharmaceuticals Due to...

The Issue: Subpotent; 6 month stability time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 9, 2014· Hospira Inc.

Recalled Item: Buprenorphine Hydrochloride Injection Recalled by Hospira Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specification: Out of Specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 8, 2014· Baxter Healthcare Corp

Recalled Item: Potassium Chloride Injection Recalled by Baxter Healthcare Corp Due to...

The Issue: Correct Labeled Product Mispack: Shipping cartons labeled as containing...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 4, 2014· Hospira Inc.

Recalled Item: Bupivacaine HCl Inj. Recalled by Hospira Inc. Due to Presence of Particulate...

The Issue: Presence of Particulate Matter: A confirmed customer complaint reported the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 28, 2014· Alvogen, Inc

Recalled Item: Oxycodone and Acetaminophen Tablets USP 10 mg/325 mg 100 count Recalled by...

The Issue: Failed Content Uniformity Specifications - The lot failed to meet the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 28, 2014· Fougera Pharmaceuticals Inc.

Recalled Item: FLUOCINONIDE GEL USP Recalled by Fougera Pharmaceuticals Inc. Due to Failed...

The Issue: Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05%...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund